Perfluorodecanoic acid as a useful pharmacologic tool for the study of peroxisome proliferation

Research output: Contribution to journalReview article

23 Citations (Scopus)

Abstract

The phenomena of peroxisome proliferation in rodent liver has received considerable attention due to its association with hepatocellular carcinoma. Chemicals that cause peroxisome proliferation include several structurally unrelated hypolipidemic drugs, phthalate esters and halogenated solvents. The mechanism by which peroxisome proliferators exert their beneficial (hypolipidemia) as well as their toxic (cancer) effects is still largely unknown. Perfluorodecanoic acid (PFDA) is a potent peroxisome proliferator in rodent liver that resembles other members of this chemical class in many aspects, including its effects on gene expression and fatty acid metabolism. However, there are many dissimilarities between PFDA and hypolipidemic peroxisome proliferators that have not been extensively explored. PFDA is unlike other peroxisome proliferators in parent compound metabolism, hypolipidemia, and tumor promotion. The present review article will discuss what is currently known about PFDA and how it may be utilized to dissect the mechanism of action of an important group of hypolipidemic drug and environmental pollutant, the peroxisome proliferators.

Original languageEnglish (US)
Pages (from-to)1123-1129
Number of pages7
JournalGeneral Pharmacology
Volume27
Issue number7
DOIs
StatePublished - Jan 1 1996

Fingerprint

Peroxisome Proliferators
Peroxisomes
Hypolipidemic Agents
Rodentia
Environmental Pollutants
Poisons
Liver
Hepatocellular Carcinoma
Neoplasms
Esters
Fatty Acids
perfluorodecanoic acid
Gene Expression

All Science Journal Classification (ASJC) codes

  • Pharmacology

Cite this

@article{089ec8b301904748bc308a41fcca7680,
title = "Perfluorodecanoic acid as a useful pharmacologic tool for the study of peroxisome proliferation",
abstract = "The phenomena of peroxisome proliferation in rodent liver has received considerable attention due to its association with hepatocellular carcinoma. Chemicals that cause peroxisome proliferation include several structurally unrelated hypolipidemic drugs, phthalate esters and halogenated solvents. The mechanism by which peroxisome proliferators exert their beneficial (hypolipidemia) as well as their toxic (cancer) effects is still largely unknown. Perfluorodecanoic acid (PFDA) is a potent peroxisome proliferator in rodent liver that resembles other members of this chemical class in many aspects, including its effects on gene expression and fatty acid metabolism. However, there are many dissimilarities between PFDA and hypolipidemic peroxisome proliferators that have not been extensively explored. PFDA is unlike other peroxisome proliferators in parent compound metabolism, hypolipidemia, and tumor promotion. The present review article will discuss what is currently known about PFDA and how it may be utilized to dissect the mechanism of action of an important group of hypolipidemic drug and environmental pollutant, the peroxisome proliferators.",
author = "{Vanden Heuvel}, {John Patrick}",
year = "1996",
month = "1",
day = "1",
doi = "10.1016/0306-3623(95)00126-3",
language = "English (US)",
volume = "27",
pages = "1123--1129",
journal = "Vascular Pharmacology",
issn = "1537-1891",
publisher = "Elsevier Inc.",
number = "7",

}

Perfluorodecanoic acid as a useful pharmacologic tool for the study of peroxisome proliferation. / Vanden Heuvel, John Patrick.

In: General Pharmacology, Vol. 27, No. 7, 01.01.1996, p. 1123-1129.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Perfluorodecanoic acid as a useful pharmacologic tool for the study of peroxisome proliferation

AU - Vanden Heuvel, John Patrick

PY - 1996/1/1

Y1 - 1996/1/1

N2 - The phenomena of peroxisome proliferation in rodent liver has received considerable attention due to its association with hepatocellular carcinoma. Chemicals that cause peroxisome proliferation include several structurally unrelated hypolipidemic drugs, phthalate esters and halogenated solvents. The mechanism by which peroxisome proliferators exert their beneficial (hypolipidemia) as well as their toxic (cancer) effects is still largely unknown. Perfluorodecanoic acid (PFDA) is a potent peroxisome proliferator in rodent liver that resembles other members of this chemical class in many aspects, including its effects on gene expression and fatty acid metabolism. However, there are many dissimilarities between PFDA and hypolipidemic peroxisome proliferators that have not been extensively explored. PFDA is unlike other peroxisome proliferators in parent compound metabolism, hypolipidemia, and tumor promotion. The present review article will discuss what is currently known about PFDA and how it may be utilized to dissect the mechanism of action of an important group of hypolipidemic drug and environmental pollutant, the peroxisome proliferators.

AB - The phenomena of peroxisome proliferation in rodent liver has received considerable attention due to its association with hepatocellular carcinoma. Chemicals that cause peroxisome proliferation include several structurally unrelated hypolipidemic drugs, phthalate esters and halogenated solvents. The mechanism by which peroxisome proliferators exert their beneficial (hypolipidemia) as well as their toxic (cancer) effects is still largely unknown. Perfluorodecanoic acid (PFDA) is a potent peroxisome proliferator in rodent liver that resembles other members of this chemical class in many aspects, including its effects on gene expression and fatty acid metabolism. However, there are many dissimilarities between PFDA and hypolipidemic peroxisome proliferators that have not been extensively explored. PFDA is unlike other peroxisome proliferators in parent compound metabolism, hypolipidemia, and tumor promotion. The present review article will discuss what is currently known about PFDA and how it may be utilized to dissect the mechanism of action of an important group of hypolipidemic drug and environmental pollutant, the peroxisome proliferators.

UR - http://www.scopus.com/inward/record.url?scp=0030273512&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030273512&partnerID=8YFLogxK

U2 - 10.1016/0306-3623(95)00126-3

DO - 10.1016/0306-3623(95)00126-3

M3 - Review article

VL - 27

SP - 1123

EP - 1129

JO - Vascular Pharmacology

JF - Vascular Pharmacology

SN - 1537-1891

IS - 7

ER -